Alphapharm submits that para (b) of the definition requires that the use of the method or process be in the "patent area". (1) Lundbeck's "pharmaceutical substance per se" submission General I set out the relevant sections in Pt 3 of Ch 6 of the Act at [17] --- [21] above. Claims 1---5 are product claims. This is because of what was known about how enantiomers are produced. Professor Banwell said:   ... It was agreed that it would be necessary to proceed via an S N 2 reaction in order to resolve the diol precursor (a single enantiomer) stereospecifically.